
handle: 10261/27252
[EN] The invention relates to a compound of structural formula (1) and the derivatives thereof, for the use thereof as a medicament, preferably as an immunosuppressive agent based on the interruption of TCR-Nck interaction.
[ES] La presente invención se refiere a un compuesto de fórmula estructural (1) y sus derivados, para su uso como medicamento. Preferiblemente como agente inmunosupresor basado en la interrupción de la interacción TCR-Nck.
A1 Solicitud de patentes con informe sobre el estado de la técnica
Consejo Superior de Investigaciones Científicas (España)
Peer reviewed
Inmunosupresores
Inmunosupresores
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
